APA

Sondhi D., Johnson L., Purpura K., Monette S., Souweidane M. M., Kaplitt M. G., Kosofsky B., Yohay K., Ballon D., Dyke J., Kaminksy S. M., Hackett N. R. & Crystal R. G. (20130718). Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. : Human gene therapy methods.

Chicago

Sondhi Dolan, Johnson Linda, Purpura Keith, Monette Sebastien, Souweidane Mark M, Kaplitt Michael G, Kosofsky Barry, Yohay Kaleb, Ballon Douglas, Dyke Jonathan, Kaminksy Stephen M, Hackett Neil R and Crystal Ronald G. 20130718. Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. : Human gene therapy methods.

Harvard

Sondhi D., Johnson L., Purpura K., Monette S., Souweidane M. M., Kaplitt M. G., Kosofsky B., Yohay K., Ballon D., Dyke J., Kaminksy S. M., Hackett N. R. and Crystal R. G. (20130718). Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. : Human gene therapy methods.

MLA

Sondhi Dolan, Johnson Linda, Purpura Keith, Monette Sebastien, Souweidane Mark M, Kaplitt Michael G, Kosofsky Barry, Yohay Kaleb, Ballon Douglas, Dyke Jonathan, Kaminksy Stephen M, Hackett Neil R and Crystal Ronald G. Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. : Human gene therapy methods. 20130718.